Genetec Corporation (TYO:4492)
Japan · Delayed Price · Currency is JPY 375.00
-8.00 (-2.09%)
Aug 19, 2026, 3:30 PM JST
Genetec Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 11,032 | 10,983 | 8,124 | 7,147 | 5,864 | 4,683 | |
Revenue Growth | 28.34% | 35.19% | 13.67% | 21.88% | 25.22% | 14.81% |
Cost of Revenue | 6,855 | 6,835 | 4,853 | 4,239 | 3,547 | 2,720 |
Gross Profit | 4,177 | 4,148 | 3,271 | 2,908 | 2,317 | 1,963 |
Selling, General & Admin | 3,359 | 3,327 | 2,577 | 2,283 | 2,211 | 1,772 |
Operating Expenses | 3,359 | 3,327 | 2,577 | 2,279 | 2,211 | 1,772 |
Operating Income | 818 | 821 | 694 | 629 | 106 | 191 |
Interest Expense | -30 | -30 | -11 | -7 | -3 | - |
Interest & Investment Income | 2 | 2 | - | - | - | - |
Currency Exchange Gain (Loss) | -12 | -6 | -1 | -5 | -7 | -7 |
Other Non Operating Income (Expenses) | 27 | 37 | - | 17 | 14 | 69 |
EBT Excluding Unusual Items | 805 | 824 | 682 | 634 | 110 | 253 |
Gain (Loss) on Sale of Assets | - | 5 | - | - | - | - |
Asset Writedown | - | - | -10 | -5 | -8 | - |
Legal Settlements | - | - | - | - | -15 | - |
Other Unusual Items | -3 | -3 | -11 | -1 | - | -137 |
Pretax Income | 802 | 826 | 661 | 628 | 87 | 116 |
Income Tax Expense | 305 | 316 | 240 | 214 | 64 | 60 |
Net Income | 497 | 510 | 421 | 414 | 23 | 56 |
Net Income to Common | 497 | 510 | 421 | 414 | 23 | 56 |
Net Income Growth | 28.76% | 21.14% | 1.69% | 1700.00% | -58.93% | -67.63% |
Shares Outstanding (Basic) | 12 | 12 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 11 | 11 |
Shares Change | 0.27% | 0.31% | 0.32% | 0.76% | 1.64% | 0.02% |
EPS (Basic) | 43.02 | 44.22 | 36.80 | 36.38 | 2.03 | 5.01 |
EPS (Diluted) | 42.60 | 43.78 | 36.23 | 35.80 | 2.03 | 4.95 |
EPS Growth | 28.49% | 20.84% | 1.20% | 1660.88% | -58.93% | -67.71% |
Free Cash Flow | - | 46 | 385 | 579 | -323 | -117 |
Free Cash Flow Per Share | - | 3.94 | 33.13 | 49.97 | -28.09 | -10.34 |
Dividend Per Share | 22.000 | 22.000 | 18.000 | 17.833 | 3.333 | 3.333 |
Dividend Growth | 22.22% | 22.22% | 0.94% | 435.01% | 0% | 0% |
Gross Margin | 37.86% | 37.77% | 40.26% | 40.69% | 39.51% | 41.92% |
Operating Margin | 7.41% | 7.47% | 8.54% | 8.80% | 1.81% | 4.08% |
Profit Margin | 4.50% | 4.64% | 5.18% | 5.79% | 0.39% | 1.20% |
Free Cash Flow Margin | - | 0.42% | 4.74% | 8.10% | -5.51% | -2.50% |
EBITDA | 1,084 | 1,065 | 849 | 774 | 259 | 227 |
EBITDA Margin | 9.83% | 9.70% | 10.45% | 10.83% | 4.42% | 4.85% |
D&A For EBITDA | 266.25 | 244 | 155 | 145 | 153 | 36 |
EBIT | 818 | 821 | 694 | 629 | 106 | 191 |
EBIT Margin | 7.41% | 7.47% | 8.54% | 8.80% | 1.81% | 4.08% |
Effective Tax Rate | 38.03% | 38.26% | 36.31% | 34.08% | 73.56% | 51.72% |
Advertising Expenses | - | 317 | 335 | 315 | 442 | 425 |